Factors Associated With the Decay of Anti-SARS-CoV-2 S1 IgG Antibodies Among Recipients of an Adenoviral Vector-Based AZD1222 and a Whole-Virion Inactivated BBV152 Vaccine

BackgroundThe magnitude of protection conferred following recovery from COVID-19 or by vaccine administration, and the duration of protective immunity developed, remains ambiguous.MethodsWe investigated the factors associated with anti-SARS-CoV-2 S1 IgG decay in 519 individuals who recovered from CO...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Sivaprakasam T. Selvavinayagam, Yean Kong Yong, Hong Yien Tan, Ying Zhang, Gurunathan Subramanian, Manivannan Rajeshkumar, Kalaivani Vasudevan, Priyanka Jayapal, Krishnasamy Narayanasamy, Dinesh Ramesh, Sampath Palani, Marie Larsson, Esaki M. Shankar, Sivadoss Raju
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-06-01
Colecção:	Frontiers in Medicine
Assuntos:	AZD1222 BBV152 COVID-19 IgG decay SARS-CoV-2 vaccination
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fmed.2022.887974/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!